224 related articles for article (PubMed ID: 25059341)
1. Elevated odds of metabolic syndrome in psoriasis: a population-based study of age and sex differences.
Danielsen K; Wilsgaard T; Olsen AO; Eggen AE; Olsen K; Cassano PA; Furberg AS
Br J Dermatol; 2015 Feb; 172(2):419-27. PubMed ID: 25059341
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.
Paschoal RS; Silva DA; Cardili RN; Souza CDS
An Bras Dermatol; 2018 Mar; 93(2):222-228. PubMed ID: 29723366
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of smoking, alcohol consumption and metabolic syndrome in patients with psoriasis.
Adışen E; Uzun S; Erduran F; Gürer MA
An Bras Dermatol; 2018 Mar; 93(2):205-211. PubMed ID: 29723384
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of metabolic syndrome in patients with psoriasis: a cross-sectional study in Singapore.
Chan WMM; Yew YW; Theng TSC; Liew CF; Oon HH
Singapore Med J; 2020 Apr; 61(4):194-199. PubMed ID: 31788703
[TBL] [Abstract][Full Text] [Related]
5. Psoriasis, cardiovascular risk factors and metabolic disorders: sex-specific findings of a population-based study.
Sondermann W; Djeudeu Deudjui DA; Körber A; Slomiany U; Brinker TJ; Erbel R; Moebus S
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):779-786. PubMed ID: 31797464
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of metabolic syndrome in Chinese psoriasis patients: A hospital-based cross-sectional study.
Gui XY; Yu XL; Jin HZ; Zuo YG; Wu C
J Diabetes Investig; 2018 Jan; 9(1):39-43. PubMed ID: 28371532
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.
Armstrong AW; Harskamp CT; Armstrong EJ
J Am Acad Dermatol; 2013 Apr; 68(4):654-662. PubMed ID: 23360868
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome and risk of incident psoriasis: prospective data from the HUNT Study, Norway.
Snekvik I; Nilsen TIL; Romundstad PR; Saunes M
Br J Dermatol; 2019 Jan; 180(1):94-99. PubMed ID: 29904911
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.
Love TJ; Qureshi AA; Karlson EW; Gelfand JM; Choi HK
Arch Dermatol; 2011 Apr; 147(4):419-24. PubMed ID: 21173301
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.
Langan SM; Seminara NM; Shin DB; Troxel AB; Kimmel SE; Mehta NN; Margolis DJ; Gelfand JM
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):556-62. PubMed ID: 22113483
[TBL] [Abstract][Full Text] [Related]
11. High burden of the metabolic syndrome and its component disorders in South Africans with psoriasis.
Goolam Mahyoodeen N; Crowther NJ; Snyman T; Pillay L; Tikly M
Int J Dermatol; 2019 May; 58(5):557-562. PubMed ID: 30565666
[TBL] [Abstract][Full Text] [Related]
12. Association between the severity of hard-to-treat psoriasis and the prevalence of metabolic syndrome: A hospital-based cross-sectional study in Jakarta, Indonesia.
Evyana D; Novianto E; Budianti WK; Krisanti RIA; Wisnu W; Wibawanti R; Nilasari H; Legiawati L; Hapsari SAR; Mutmainnah E
PLoS One; 2024; 19(4):e0302391. PubMed ID: 38683749
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and psoriasis: a study in 97 patients.
Ferdinando LB; Fukumoto PK; Sanches S; Fabricio LHZ; Skare TL
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):368-373. PubMed ID: 30133617
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome is associated with an increased risk of psoriasis: A nationwide population-based study.
Kim HN; Han K; Park YG; Lee JH
Metabolism; 2019 Oct; 99():19-24. PubMed ID: 31279740
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study.
Milčić D; Janković S; Vesić S; Milinković M; Marinković J; Ćirković A; Janković J
An Bras Dermatol; 2017; 92(1):46-51. PubMed ID: 28225956
[TBL] [Abstract][Full Text] [Related]
16. Association between psoriasis and the metabolic syndrome. A cross-sectional study.
Cohen AD; Sherf M; Vidavsky L; Vardy DA; Shapiro J; Meyerovitch J
Dermatology; 2008; 216(2):152-5. PubMed ID: 18216477
[TBL] [Abstract][Full Text] [Related]
17. An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.
Singh S; Young P; Armstrong AW
PLoS One; 2017; 12(7):e0181039. PubMed ID: 28719618
[TBL] [Abstract][Full Text] [Related]
18. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Metabolic Syndrome Among Patients with Psoriasis Treated with TNF Inhibitors and the Effects of Anti-TNF Therapy on Their Lipid Profile: A Prospective Cohort Study.
Botelho KP; Pontes MAA; Rodrigues CEM; Freitas MVC
Metab Syndr Relat Disord; 2020 Apr; 18(3):154-160. PubMed ID: 31928509
[No Abstract] [Full Text] [Related]
20. Relationship between psoriasis and metabolic syndrome: a systematic review.
Singh S; Young P; Armstrong AW
G Ital Dermatol Venereol; 2016 Dec; 151(6):663-677. PubMed ID: 27589483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
